Patents by Inventor Alan Meyer

Alan Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
    Publication number: 20250262149
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Application
    Filed: April 25, 2025
    Publication date: August 21, 2025
    Inventor: Alan Meyer
  • AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
    Publication number: 20250248931
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Application
    Filed: April 25, 2025
    Publication date: August 7, 2025
    Inventor: Alan Meyer
  • AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
    Publication number: 20250248930
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Application
    Filed: April 25, 2025
    Publication date: August 7, 2025
    Inventor: Alan Meyer
  • Aqueous ophthalmic solutions of phentolamine and medical uses thereof
    Patent number: 12350366
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Grant
    Filed: December 13, 2023
    Date of Patent: July 8, 2025
    Assignee: Opus Genetics, Inc.
    Inventor: Alan Meyer
  • AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
    Publication number: 20240285519
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Application
    Filed: December 13, 2023
    Publication date: August 29, 2024
    Inventor: Alan Meyer
  • METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE
    Publication number: 20240050412
    Abstract: The invention provides methods, compositions, and kits containing phentolamine for improving visual performance. In particular, the invention provides improvement in visual performance, such as improvement in visual acuity, by daily ophthalmic administration of a phentolamine solution to an eye of a patient at or near the bedtime of the patient for an extended duration while minimizing the occurrence of adverse side effects, such as eye redness during the patient's waking hours.
    Type: Application
    Filed: June 14, 2023
    Publication date: February 15, 2024
    Inventor: Alan Meyer
  • Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
    Patent number: 11717510
    Abstract: The invention provides methods, compositions, and kits containing phentolamine for improving visual performance. In particular, the invention provides improvement in visual performance, such as improvement in visual acuity, by daily ophthalmic administration of a phentolamine solution to an eye of a patient at or near the bedtime of the patient for an extended duration while minimizing the occurrence of adverse side effects, such as eye redness during the patient's waking hours.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: August 8, 2023
    Assignee: Ocuphire Pharma, Inc.
    Inventor: Alan Meyer
  • METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE
    Publication number: 20210338638
    Abstract: The invention provides methods, compositions, and kits containing phentolamine for improving visual performance. In particular, the invention provides improvement in visual performance, such as improvement in visual acuity, by daily ophthalmic administration of a phentolamine solution to an eye of a patient at or near the bedtime of the patient for an extended duration while minimizing the occurrence of adverse side effects, such as eye redness during the patient's waking hours.
    Type: Application
    Filed: April 13, 2021
    Publication date: November 4, 2021
    Inventor: Alan Meyer
  • Aqueous ophthalmic solutions of phentolamine and medical uses thereof
    Patent number: 11090261
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: August 17, 2021
    Assignee: Ocuphire Pharma, Inc.
    Inventor: Alan Meyer
  • Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
    Patent number: 11000509
    Abstract: The invention provides methods, compositions, and kits containing phentolamine for improving visual performance. In particular, the invention provides improvement in visual performance, such as improvement in visual acuity, by daily ophthalmic administration of a phentolamine solution to an eye of a patient at or near the bedtime of the patient for an extended duration while minimizing the occurrence of adverse side effects, such as eye redness during the patient's waking hours.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: May 11, 2021
    Assignee: Ocuphire Pharma, Inc.
    Inventor: Alan Meyer
  • Aqueous ophthalmic solutions of phentolamine and medical uses thereof
    Patent number: 10772829
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: September 15, 2020
    Assignee: Ocuphire Pharma, Inc.
    Inventor: Alan Meyer
  • AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
    Publication number: 20190358152
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Application
    Filed: April 30, 2019
    Publication date: November 28, 2019
    Inventor: Alan Meyer
  • AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
    Publication number: 20190254963
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Application
    Filed: April 30, 2019
    Publication date: August 22, 2019
    Inventor: Alan Meyer
  • Aqueous ophthalmic solutions of phentolamine and medical uses thereof
    Patent number: 10278918
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: May 7, 2019
    Assignee: Ocuphire Pharma, Inc.
    Inventor: Alan Meyer
  • METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE
    Publication number: 20180221340
    Abstract: The invention provides methods, compositions, and kits containing phentolamine for improving visual performance. In particular, the invention provides improvement in visual performance, such as improvement in visual acuity, by daily ophthalmic administration of a phentolamine solution to an eye of a patient at or near the bedtime of the patient for an extended duration while minimizing the occurrence of adverse side effects, such as eye redness during the patient's waking hours.
    Type: Application
    Filed: September 25, 2017
    Publication date: August 9, 2018
    Inventor: Alan Meyer
  • AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
    Publication number: 20180221274
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Application
    Filed: October 13, 2017
    Publication date: August 9, 2018
    Inventor: Alan Meyer
  • Aqueous ophthalmic solutions of phentolamine and medical uses thereof
    Patent number: 9795560
    Abstract: The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: October 24, 2017
    Assignee: Ocularis Pharma, LLC
    Inventor: Alan Meyer
  • Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
    Patent number: 9789088
    Abstract: The invention provides methods, compositions, and kits containing phentolamine for improving visual performance. In particular, the invention provides improvement in visual performance, such as improvement in visual acuity, by daily ophthalmic administration of a phentolamine solution to an eye of a patient at or near the bedtime of the patient for an extended duration while minimizing the occurrence of adverse side effects, such as eye redness during the patient's waking hours.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: October 17, 2017
    Assignee: Ocularis Pharma, LLC
    Inventor: Alan Meyer
  • System and method for compiling intellectual property asset data
    Patent number: 9305278
    Abstract: An access server computing system scrapes a set of records maintained by a target computing system in a database which is only made accessible over the Internet with a limited protocol query and an access challenge. The access server accesses the target computing system through an Internet browser interface based on emulating a user query made through the limited protocol, including by automatically passing locator identifier fields to retrieve a corresponding set of record which are stored in the first database.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: April 5, 2016
    Assignee: Patent Savant, LLC
    Inventors: John Nicholas Gross, Ken Sale, Alan Meyer, Ken Boasso
  • METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE
    Publication number: 20160051515
    Abstract: The invention provides methods, compositions, and kits containing phentolamine for improving visual performance. In particular, the invention provides improvement in visual performance, such as improvement in visual acuity, by daily ophthalmic administration of a phentolamine solution to an eye of a patient at or near the bedtime of the patient for an extended duration while minimizing the occurrence of adverse side effects, such as eye redness during the patient's waking hours.
    Type: Application
    Filed: June 30, 2015
    Publication date: February 25, 2016
    Inventor: Alan Meyer